reference/16751591

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16751591

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1481
issn	1476-5551 0887-6924
issueIdentifier	7
pageRange	1475-1481
publicationName	Leukemia
startingPage	1475
bibliographicCitation	Pfeifer H, Lange T, Wystub S, Wassmann B, Maier J, Binckebanck A, Giagounidis A, Stelljes M, Schmalzing M, Dührsen U, Wunderle L, Serve H, Brück P, Schmidt A, Hoelzer D, Ottmann OG. Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia. Leukemia. 2012 Jul;26(7):1475–81. doi: 10.1038/leu.2012.5. PMID: 22230800.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3d2e07d037840a08025d69f8f3ab424 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9b7aae99a271384a9beb9a16659d275 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e312659042562ff98defa2212e6f8f9d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ed0736fc3251c1923cdd76c85493a41 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91ae161cab73d5af9e26a62d8c0d360d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e96e9584b86bea4180a3bd71379f7745 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a81f7b9eb4ec5d136b24fc76d7d64a72 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be5185d2db691128f656a70ed0cd3bda http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c9dbe2296a7d120a2c498d46770f00a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2bbc4ca714a3692fd581a6bbc87505ae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9cb6a0f0afaf330ebf1e7ee28bbb70c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f50f4bc864ffec6dd38346746337df52 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7061be1e924497b7f9ac84aa99a5becd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_326be7c51e3a4d48559773948e2077eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0bf4874f574420a2a11160554bc2b657 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3915c7a343444cdb65f4ce2635104ff5
date	2012-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/leu.2012.5 https://pubmed.ncbi.nlm.nih.gov/22230800
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5536 https://portal.issn.org/resource/ISSN/1476-5551 https://portal.issn.org/resource/ISSN/0887-6924
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia
discusses	http://id.nlm.nih.gov/mesh/M0019167 http://id.nlm.nih.gov/mesh/M0024527 http://id.nlm.nih.gov/mesh/M0391958 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0016884 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0018260
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/11 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8870 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8300 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11043

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID613 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595

Total number of triples: 53.